PROBIOMED , S . A . DE C . V .
PROBIOMED has delivered results , proving its commitment to biotech developments able to help Mexico ’ s population
PROBIOMED is Mexico ’ s leading biopharmaceutical company , investing in the biotechnology and biosimilar medical products fields and obtaining excellent results . PROBIOMED began selling APIs in 1970 before vertically integrating with first generic drugs and then biosimilar medical products . PROBIOMED is the only company in Mexico that develops from actual genes up to finished products . Its foreign market currently consists of 14 countries in four continents .
The company ’ s purpose for developing medical products from biotechnology is to improve treatment of chronic-degenerative conditions such as cancer , RA , diabetes , multiple sclerosis , CKD , and other socially- and economicallyimpactful diseases . Jaime Uribe de la Mora is PROBIOMED ’ s founder and president ; Uribe ’ s insight into the pharmaceutical industry has
80 March 2016